Neurocrine Biosciences | 资产

Assets 更改 日
AbbVie USD 148.87B 12.65B 2024-03
Acadia Pharmaceuticals USD 855.1M 106.15M 2024-03
Agios Pharmaceuticals USD 849.71M 87.41M 2024-03
ALKERMES USD 2.12B 12.33M 2024-03
Alnylam Pharmaceuticals USD 3.82B 5.49M 2024-03
Amgen USD 92.98B 4.17B 2024-03
Biogen USD 26.57B 277.2M 2024-03
BioMarin Pharmaceutical USD 6.87B 31.07M 2024-03
Cytokinetics USD 808.08M 16.23M 2024-03
Dynavax Technologies USD 986.56M 10.53M 2024-03
Exelixis USD 2.8B 173.16M 2024-03
Gilead Sciences USD 56.29B 5.83B 2024-03
Halozyme Therapeutics USD 1.84B 108.26M 2024-03
Incyte USD 7.14B 353.5M 2024-03
Intra Cellular Therapies USD 747.04M 18.74M 2024-03
Ionis Pharmaceuticals USD 2.76B 226.14M 2024-03
Neurocrine Biosciences USD 3.47B 624.2M 2024-03
Pfizer USD 221.1B 6.07B 2024-03
Prothena USD 623.19M 73.19M 2024-03
Regeneron Pharmaceuticals USD 34.37B 1.29B 2024-03
Repligen USD 2.85B 1.9B 2024-03
Sarepta Therapeutics USD 3.22B 114.68M 2024-03
Teva Pharmaceutical Industries USD 42.77B 706M 2024-03
Ultragenyx Pharmaceutical USD 1.31B 183.93M 2024-03
Vertex Pharmaceuticals USD 23.92B 2.19B 2024-03



Neurocrine Biosciences 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.